These include muscle weakness (difficulty climbing stairs, rising from a chair, or lifting objects), persistent muscle pain or tenderness, visible muscle swelling or changes in muscle appearance, or dark-colored urine, which may indicate rhabdomyolysisa rare but serious condition involving muscle breakdown
However research costs can go up to $3,000 monthly making it the most expensive option among the three for long term research
It is available as a reference material
Emerging evidence indicates that lipid traits may have a role in DR as well, though work to understand this mechanism is still being conducted [79]
Abstract Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control